Urgent appeal: EU has to ensure a sustainable supply of drugs!

Urgent appeal: EU has to ensure a sustainable supply of drugs!

Laimgrubengasse 10, 1060 Wien, Österreich - Sylvia Hofinger, managing director of the specialist association of the chemical industry in Austria (FCIO), warns of the alarming dependencies in the pharmaceutical sector. In allusion to the energy crisis, its message sounds clear: the EU is in a similarly critical location in the supply of essential drugs as in Russian energy sources. According to Hofinger, 60-80 percent of the pharmaceutical products from Asia, especially China, now come, which could have catastrophic consequences in the event of delivery bottlenecks. It calls for strengthening local production capacities to counteract this risk, as well as ots.at

A central topic is the planned critical medicines act (CMA), which is intended to strengthen the security of supply with essential drugs. However, Hofinger criticizes that current EU measures, such as the regulations for the treatment of municipal wastewater, could have the opposite effect. These regulations could increase the costs for pharmaceutical companies in Austria to three -digit million amounts annually, which in turn could endanger low -priced medication. "Apparently the right hand does not know what the left is doing," says Hofinger, who criticizes the lack of coordination between different legislation. The revision of the specifications for pharmaceutical supply required by her is intended to ensure that the practicality is in the foreground in order to avoid unwanted consequences, adds fcio.at .

The Hofinger reviews and demands are not only up to date, but also reflect the challenges that the industry has experienced since Corona pandemic. After the pandemic, diversification of the supply chains is essential. According to Hofinger, a sign of the relevance of the chemical-pharmaceutical industry in crisis times must not be underestimated, since their products contribute decisively to combat global challenges, the more important is robust and reliable care. The chemical industry therefore not only falls into the "system -relevant" category, but must also be recognized as the key to future health solutions.